Dehydro-3-epiandrosterone: Difference between revisions

Jump to navigation Jump to search
Dayana Davidis (talk | contribs)
No edit summary
Dayana Davidis (talk | contribs)
No edit summary
Line 5: Line 5:
==Overview==
==Overview==
'''Dehydro-3-epiandrosterone''' or dehydroepiandrosterone or DHEA is the main secretory product of the suprarenal cortex. The physiologic significance of DHEA is not yet proven and supplementation is not yet approved by FDA.
'''Dehydro-3-epiandrosterone''' or dehydroepiandrosterone or DHEA is the main secretory product of the suprarenal cortex. The physiologic significance of DHEA is not yet proven and supplementation is not yet approved by FDA.


==Physiology==
==Physiology==

Revision as of 21:31, 13 February 2014

WikiDoc Resources for Dehydro-3-epiandrosterone

Articles

Most recent articles on Dehydro-3-epiandrosterone

Most cited articles on Dehydro-3-epiandrosterone

Review articles on Dehydro-3-epiandrosterone

Articles on Dehydro-3-epiandrosterone in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Dehydro-3-epiandrosterone

Images of Dehydro-3-epiandrosterone

Photos of Dehydro-3-epiandrosterone

Podcasts & MP3s on Dehydro-3-epiandrosterone

Videos on Dehydro-3-epiandrosterone

Evidence Based Medicine

Cochrane Collaboration on Dehydro-3-epiandrosterone

Bandolier on Dehydro-3-epiandrosterone

TRIP on Dehydro-3-epiandrosterone

Clinical Trials

Ongoing Trials on Dehydro-3-epiandrosterone at Clinical Trials.gov

Trial results on Dehydro-3-epiandrosterone

Clinical Trials on Dehydro-3-epiandrosterone at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Dehydro-3-epiandrosterone

NICE Guidance on Dehydro-3-epiandrosterone

NHS PRODIGY Guidance

FDA on Dehydro-3-epiandrosterone

CDC on Dehydro-3-epiandrosterone

Books

Books on Dehydro-3-epiandrosterone

News

Dehydro-3-epiandrosterone in the news

Be alerted to news on Dehydro-3-epiandrosterone

News trends on Dehydro-3-epiandrosterone

Commentary

Blogs on Dehydro-3-epiandrosterone

Definitions

Definitions of Dehydro-3-epiandrosterone

Patient Resources / Community

Patient resources on Dehydro-3-epiandrosterone

Discussion groups on Dehydro-3-epiandrosterone

Patient Handouts on Dehydro-3-epiandrosterone

Directions to Hospitals Treating Dehydro-3-epiandrosterone

Risk calculators and risk factors for Dehydro-3-epiandrosterone

Healthcare Provider Resources

Symptoms of Dehydro-3-epiandrosterone

Causes & Risk Factors for Dehydro-3-epiandrosterone

Diagnostic studies for Dehydro-3-epiandrosterone

Treatment of Dehydro-3-epiandrosterone

Continuing Medical Education (CME)

CME Programs on Dehydro-3-epiandrosterone

International

Dehydro-3-epiandrosterone en Espanol

Dehydro-3-epiandrosterone en Francais

Business

Dehydro-3-epiandrosterone in the Marketplace

Patents on Dehydro-3-epiandrosterone

Experimental / Informatics

List of terms related to Dehydro-3-epiandrosterone

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Dayana Davidis, M.D. [2]

Overview

Dehydro-3-epiandrosterone or dehydroepiandrosterone or DHEA is the main secretory product of the suprarenal cortex. The physiologic significance of DHEA is not yet proven and supplementation is not yet approved by FDA.

Physiology

Production

Dehydroepiandrosterone or DHEA is secreted by the adrenal glands, which convert it from the hormone pregnenolone, a hormone secreted in the brain that is converted from cholesterol. DHEA is the basic hormone that the adrenal cortex uses to synthesise all the sex hormones including testosterone, progesterone and oestrogen and the stress hormone cortisol. It is the most abundant hormone in the body, however by age 40 its production deceases by half its peak age, 20, by age 75 it drops to 10 percent its peak.

All studies to date were not conclusive enough to prove that supplementation with DHEA would help increase its production in humans, animals studies have shown promise however humans metabolise DHEA differently than animals

Effects And Uses

DHEA is a hormone of the androgen family and it is secreted by the adrenal gland. A number of ongoing studies are conducted to link low levels of DHEA to premature ageing, low immunity, low and weak muscle mass, joint pain and arthritis pain, low energy, low stamina and even to fertility problems in women, impaired thinking in elderly and progression of Alzheimer's.

Claims have been found to link low levels of DHEA to obesity, metabolic syndrome, abnormal cholesterol levels and increased waistline. However studies were inconclusive to prove that supplementation with DHEA will help increase its production in humans.

Differential Diagnosis

DHEA is converted to testosterone in women and to oestrogen in men.

Testing for adrenal imbalance would indicate a reduced DHEA.

Decreased

Increased

References

  1. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:77 ISBN 1591032016
  2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:68 ISBN 140510368X

Acknowledgements

The content on this page was first contributed by Editor-In-Chief: C. Michael Gibson, M.S., M.D. [3]

List of contributors:


Suggested Reading and Key General References

Suggested Links and Web Resources

For Patients

Template:WH Template:WS